-
公开(公告)号:US11638723B2
公开(公告)日:2023-05-02
申请号:US17173632
申请日:2021-02-11
申请人: Assistance Publique—Hopitaux de Paris , Fondation Imagine—Institut des Maladies Génétiques , Université Paris Cité , Institut National de la Santé et de la Recherche Médicale (INSERM)
发明人: Isabelle André , Marina Cavazzana , Kuiying Ma , John Tchen , Tayebeh-Shabi Soheili , Ranjita Devi Moirangthem
摘要: The invention relates to an in vitro method to generate T cell progenitors, comprising the step of culturing CD34+ cells in a medium containing TNF-alpha and/or an antagonist of the Aryl hydrocarbon/Dioxin receptor, in particular StemRegenin 1 (SR1), in presence of a Notch ligand and optionally a fibronectin fragment.
-
公开(公告)号:US11642376B2
公开(公告)日:2023-05-09
申请号:US17173668
申请日:2021-02-11
申请人: Assistance Publique—Hopitaux de Paris , Fondation Imagine—Institut des Maladies Génétiques , Université Paris Cité , Institut National de la Santé et de la Recherche Médicale (INSERM)
发明人: Isabelle André , Marina Cavazzana , Kuiying Ma , John Tchen , Tayebeh-Shabi Soheili , Ranjita Devi Moirangthem
IPC分类号: A61K48/00 , C12N5/00 , A61K35/17 , C12N5/0783 , A01K67/00
CPC分类号: A61K35/17 , C12N5/0636 , C12N2501/125 , C12N2501/145 , C12N2501/2307 , C12N2501/25 , C12N2501/26 , C12N2501/42 , C12N2506/11 , C12N2533/52
摘要: The invention relates to an in vitro method to generate T cell progenitors, comprising the step of culturing CD34+ cells in a medium containing TNF-alpha and/or an antagonist of the Aryl hydro-carbon/Dioxin receptor, in particular StemRegenin 1 (SR1), in presence of a Notch ligand and optionally a fibronectin fragment.
-
公开(公告)号:US11426430B2
公开(公告)日:2022-08-30
申请号:US17010208
申请日:2020-09-02
申请人: Assistance Publique—Hopitaux de Paris , Fondation Imagine—Institut des Maladies Génétiques , Université de Paris Cité , Institut National de la Santé et de la Recherche Médicale (INSERM)
发明人: Isabelle André , Marina Cavazzana , Kuiying Ma , John Tchen , Tayebeh-Shabi Soheili , Ranjita Devi Moirangthem
IPC分类号: C12N5/00 , C12N5/02 , A61K35/17 , C12N5/0783 , A61K48/00
摘要: The invention relates to an in vitro method to generate T cell progenitors, comprising the step of culturing CD34+ cells in a medium containing TNF-alpha and/or an antagonist of the Aryl hydro-carbon/Dioxin receptor, in particular StemRegenin 1 (SR1), in presence of a Notch ligand and optionally a fibronectin fragment.
-
-